神経疾患診断薬の世界市場レポート 2025年

神経疾患診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.1%で166億米ドルに成長します。予測期間の成長は、意識と教育の高まり、ヘルスケア支出の増加、ヘルスケアサービスへのアクセスの改善、診断センターの拡大、個別化医療の採用の高まりに起因しています。予測期間における主な動向には、神経画像技術の進歩、ウェアラブルデバイスと遠隔モニタリング技術の採用、バイオマーカー探索と遺伝子検査の進歩、人工知能と機械学習の統合、ポイントオブケア診断機器の開発などがあります。

アルツハイマー病の有病率の増加は、今後数年間の神経疾患診断薬市場の拡大を促進すると予想されます。アルツハイマー病は進行性の神経変性疾患であり、記憶、推論、問題解決などの認知能力が徐々に低下することが特徴です。この疾患は、特定の遺伝子の突然変異や変異などの遺伝的要因、脳内のアミロイド斑やタウのもつれの蓄積、慢性炎症、血管の問題、ライフスタイルの影響などが複合的に関与しています。神経疾患診断薬は、高度な画像診断技術、バイオマーカー分析、認知機能評価を通じて早期かつ正確な発見を容易にすることで、アルツハイマー病の管理を支援します。例えば、2024年9月、オーストラリアの政府機関であるAustralian Institute of Health and Welfare（オーストラリア保健福祉研究所）は、2023年にはオーストラリアで約41万1,100人が認知症を患っており、そのうち女性は約25万7,500人、男性は約15万3,700人であると報告しました。したがって、アルツハイマー病の有病率の上昇が神経疾患診断薬市場の成長に寄与しています。

神経疾患診断薬市場の主要企業は、神経疾患の影響を受ける世界10億人のニーズに対応するため、神経疾患定量化ソフトウェアなどの革新的ソリューションの開発に注力しています。神経疾患定量化ソフトウェアは、神経疾患における脳機能や疾患の進行を評価・追跡するために設計されたツールです。例えば、2024年1月、スペインに本社を置くバイオテクノロジー企業Quibim社は、初期段階の神経疾患定量化のためのAI駆動型ソフトウェアQP-Brainを発表しました。QP-Brainは、神経疾患による脳組織の変化を測定するためにキビムが開発した先進的な神経画像解析ツールです。QP-Brainの特長は、AIを活用した自動セグメンテーションと包括的な体積分析であり、臨床と調査の両方の目的で脳の構造変化に関する正確な洞察を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界神経疾患診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の神経疾患診断薬市場：成長率分析
• 世界の神経疾患診断薬市場の実績：規模と成長, 2019-2024
• 世界の神経疾患診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界神経疾患診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の神経疾患診断薬市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• 試薬
• キット
• ソフトウェア
• サービス
• 世界の神経疾患診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫測定
• ポリメラーゼ連鎖反応（PCR）技術
• 世界の神経疾患診断薬市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルツハイマー病
• 痴呆
• パーキンソン病
• てんかん
• 外傷性脳損傷
• その他の病気の種類
• 世界の神経疾患診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断センター
• 学術研究機関
• 世界の神経疾患診断薬市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳波検査（EEG）装置
• 磁気共鳴画像（MRI）装置
• コンピュータ断層撮影（CT）スキャナー
• 陽電子放出断層撮影（PET）スキャナー
• 腰椎穿刺装置
• 超音波装置
• 神経刺激装置
• 経頭蓋磁気刺激（TMS）装置
• 世界の神経疾患診断薬市場、試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生化学試薬
• 抗体
• DNAプローブ
• RNAプローブ
• 酵素免疫測定（ELISA）試薬
• ポリメラーゼ連鎖反応（PCR）試薬
• サンプル採取試薬
• 世界の神経疾患診断薬市場キットの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断検査キット
• 遺伝子検査キット
• バイオマーカー検出キット
• 免疫測定キット
• ポイントオブケア検査キット
• 神経疾患のスクリーニングキット
• 世界の神経疾患診断薬市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像解析用診断ソフトウェア
• データ管理ソフトウェア
• 臨床意思決定支援ソフトウェア
• 患者管理ソフトウェア
• 検査情報管理システム（LIMS）
• ニューロインフォマティクスソフトウェア
• 遠隔医療ソフトウェア
• 世界の神経疾患診断薬市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断検査サービス
• コンサルティングサービス
• トレーニングおよびサポートサービス
• 機器のメンテナンスおよび修理サービス
• 遠隔医療サービス
• データ分析サービス
• 研究開発サービス

第7章 地域別・国別分析

• 世界の神経疾患診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の神経疾患診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経疾患診断薬市場：競合情勢
• 神経疾患診断薬市場：企業プロファイル
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic plc
• Amgen Inc.
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Boston Scientific Corporation
• Neurocrine Biosciences Inc.
• Neusoft Medical Systems Co.Ltd.
• Nihon Kohden Corporation
• Natus Medical Incorporated
• Esaote S.p.A
• Canon Medical Systems Corporation
• NeuroPace Inc.
• Lifelines Neuro Company LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 神経疾患診断薬市場2029：新たな機会を提供する国
• 神経疾患診断薬市場2029：新たな機会を提供するセグメント
• 神経疾患診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Neurological disorder diagnostics involve methods and technologies used to identify, assess, and monitor diseases affecting the nervous system, including the brain, spinal cord, and nerves. This field utilizes advanced imaging techniques, biomarker analysis, genetic testing, and cognitive assessments to detect abnormalities, determine the presence and progression of diseases, and guide treatment strategies for various neurological conditions.

The main components in the neurological disorder diagnostics market include instruments, reagents, kits, software, and services. Instruments refer to the physical devices used for diagnosing neurological disorders. Technologies in this field include immunoassays and polymerase chain reaction (PCR) techniques. The diseases covered range from Alzheimer's disease and dementia to Parkinson's disease, epilepsy, traumatic brain injury, and more. End users of these diagnostics include hospitals and clinics, diagnostic centers, and academic and research institutes.

The neurological disorder diagnostics market research report is one of a series of new reports from The Business Research Company that provides neurological disorder diagnostics market statistics, including the neurological disorder diagnostics industry global market size, regional shares, competitors with neurological disorder diagnostics market share, detailed neurological disorder diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the neurological disorder diagnostics industry. These neurological disorder diagnostics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurological disorder diagnostics market size has grown strongly in recent years. It will grow from $11.75 $ billion in 2024 to $12.61 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increase in prevalence of neurological disorders, increase in ageing population, growth in emphasis on early diagnosis and disease management, growth in awareness of neurological disorders, and increase focus on early diagnosis.

The neurological disorder diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.6 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing awareness and education, increasing healthcare expenditure, improved access to healthcare services, expansion of diagnostic centers, and rising adoption of personalized medicine. Major trends in the forecast period include advancements in neuroimaging techniques, adoption of wearable devices and remote monitoring technologies, advancements in biomarker discovery and genetic testing, integration of artificial intelligence and machine learning, and development of point-of-care diagnostic devices.

The growing prevalence of Alzheimer's disease is expected to drive the expansion of the neurological disorder diagnostics market in the coming years. Alzheimer's disease is a progressive neurodegenerative condition marked by a gradual deterioration in cognitive abilities, including memory, reasoning, and problem-solving. The disease involves a combination of genetic factors, such as certain gene mutations and variations, the buildup of amyloid plaques and tau tangles in the brain, chronic inflammation, vascular problems, and lifestyle influences. Neurological disorder diagnostics aid in managing Alzheimer's disease by facilitating early and accurate detection through advanced imaging techniques, biomarker analysis, and cognitive assessments. For example, in September 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that in 2023, around 411,100 people in Australia were living with dementia, including approximately 257,500 women and 153,700 men. Therefore, the rising prevalence of Alzheimer's disease is contributing to the growth of the neurological disorder diagnostics market.

Leading companies in the neurological disorder diagnostics market are concentrating on developing innovative solutions, such as neurological disease quantification software, to address the needs of the one billion people globally affected by neurological diseases. Neurological disease quantification software is a tool designed to assess and track brain function and the progression of diseases in neurological conditions. For example, in January 2024, Quibim, a biotechnology company based in Spain, introduced QP-Brain, an AI-driven software for early-stage neurological disease quantification. QP-Brain is an advanced neuroimaging analysis tool developed by Quibim to measure changes in brain tissue due to neurological diseases. Its standout features include AI-powered automated segmentation and comprehensive volumetric analysis, providing accurate insights into brain structural changes for both clinical and research purposes.

In February 2023, Lantheus, a US-based pharmaceutical manufacturer, acquired Cerveau Technologies for an undisclosed amount. This acquisition enhances Lantheus' diagnostic capabilities for Alzheimer's disease with Cerveau's tau-targeting PET imaging agent, MK-6240, improving the ability to diagnose, stage, and monitor the disease while supporting the development of new treatments. Cerveau Technologies, based in the US, specializes in diagnostic technologies for neurological disorders, particularly neurodegenerative diseases such as Alzheimer's.

Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation

North America was the largest region in the neurological disorder diagnostics market in 2023. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurological disorder diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurological disorder diagnostics market consists of revenues earned by entities by providing services such as neuroimaging, electrophysiological testing, genetic analysis, cerebrospinal fluid examination, neuropsychological assessments, and laboratory tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurological disorder diagnostics market also includes sales of imaging devices, biomarker tests, and cognitive assessment tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurological Disorder Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurological disorder diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurological disorder diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurological disorder diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Instruments; Reagents; Kits; Software; Services
• 2) By Technology: Immunoassay; Polymerase Chain Reaction (PCR) Techniques
• 3) By Disease Type: Alzheimer's Disease; Dementia; Parkinson's Disease; Epilepsy; Traumatic Brain Injury; Other Disease Types
• 4) By End User: Hospitals And Clinics; Diagnostic Centers; Academic And Research Institutes
• Subsegments:
• 1) By Instruments: Electroencephalography (EEG) Machines; Magnetic Resonance Imaging (MRI) Machines; Computed Tomography (CT) Scanners; Positron Emission Tomography (PET) Scanners; Lumbar Puncture Equipment; Ultrasound Devices; Neurostimulation Devices; Transcranial Magnetic Stimulation (TMS) Devices;
• 2) By Reagents: Biochemical Reagents; Antibodies; DNA Probes; RNA Probes; Enzyme-linked Immunosorbent Assay (ELISA) Reagents; Polymerase Chain Reaction (PCR) Reagents; Sample Collection Reagents
• 3) By Kits: Diagnostic Test Kits; Genetic Testing Kits; Biomarker Detection Kits; Immunoassay Kits; Point-of-Care Testing Kits; Screening Kits for Neurological Disorders
• 4) By Software: Diagnostic Software for Imaging Analysis; Data Management Software; Clinical Decision Support Software; Patient Management Software; Laboratory Information Management Systems (LIMS); Neuroinformatics Software; Telemedicine Software
• 5) By Services: Diagnostic Testing Services; Consultation Services; Training and Support Services; Maintenance and Repair Services for Equipment; Telehealth Services; Data Analysis Services; Research and Development Services
• Companies Mentioned: Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurological Disorder Diagnostics Market Characteristics

3. Neurological Disorder Diagnostics Market Trends And Strategies

4. Neurological Disorder Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Neurological Disorder Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neurological Disorder Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neurological Disorder Diagnostics Market Growth Rate Analysis
• 5.4. Global Neurological Disorder Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neurological Disorder Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neurological Disorder Diagnostics Total Addressable Market (TAM)

6. Neurological Disorder Diagnostics Market Segmentation

• 6.1. Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Reagents
• Kits
• Software
• Services
• 6.2. Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay
• Polymerase Chain Reaction (PCR) Techniques
• 6.3. Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Dementia
• Parkinson's Disease
• Epilepsy
• Traumatic Brain Injury
• Other Disease Types
• 6.4. Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Academic And Research Institutes
• 6.5. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electroencephalography (EEG) Machines
• Magnetic Resonance Imaging (MRI) Machines
• Computed Tomography (CT) Scanners
• Positron Emission Tomography (PET) Scanners
• Lumbar Puncture Equipment
• Ultrasound Devices
• Neurostimulation Devices
• Transcranial Magnetic Stimulation (TMS) Devices
• 6.6. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biochemical Reagents
• Antibodies
• DNA Probes
• RNA Probes
• Enzyme-linked Immunosorbent Assay (ELISA) Reagents
• Polymerase Chain Reaction (PCR) Reagents
• Sample Collection Reagents
• 6.7. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Test Kits
• Genetic Testing Kits
• Biomarker Detection Kits
• Immunoassay Kits
• Point-of-Care Testing Kits
• Screening Kits for Neurological Disorders
• 6.8. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Software for Imaging Analysis
• Data Management Software
• Clinical Decision Support Software
• Patient Management Software
• Laboratory Information Management Systems (LIMS)
• Neuroinformatics Software
• Telemedicine Software
• 6.9. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Testing Services
• Consultation Services
• Training and Support Services
• Maintenance and Repair Services for Equipment
• Telehealth Services
• Data Analysis Services
• Research and Development Services

7. Neurological Disorder Diagnostics Market Regional And Country Analysis

• 7.1. Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurological Disorder Diagnostics Market

• 8.1. Asia-Pacific Neurological Disorder Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurological Disorder Diagnostics Market

• 9.1. China Neurological Disorder Diagnostics Market Overview
• 9.2. China Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurological Disorder Diagnostics Market

• 10.1. India Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurological Disorder Diagnostics Market

• 11.1. Japan Neurological Disorder Diagnostics Market Overview
• 11.2. Japan Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurological Disorder Diagnostics Market

• 12.1. Australia Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurological Disorder Diagnostics Market

• 13.1. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurological Disorder Diagnostics Market

• 14.1. South Korea Neurological Disorder Diagnostics Market Overview
• 14.2. South Korea Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurological Disorder Diagnostics Market

• 15.1. Western Europe Neurological Disorder Diagnostics Market Overview
• 15.2. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurological Disorder Diagnostics Market

• 16.1. UK Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurological Disorder Diagnostics Market

• 17.1. Germany Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurological Disorder Diagnostics Market

• 18.1. France Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurological Disorder Diagnostics Market

• 19.1. Italy Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurological Disorder Diagnostics Market

• 20.1. Spain Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurological Disorder Diagnostics Market

• 21.1. Eastern Europe Neurological Disorder Diagnostics Market Overview
• 21.2. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurological Disorder Diagnostics Market

• 22.1. Russia Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurological Disorder Diagnostics Market

• 23.1. North America Neurological Disorder Diagnostics Market Overview
• 23.2. North America Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurological Disorder Diagnostics Market

• 24.1. USA Neurological Disorder Diagnostics Market Overview
• 24.2. USA Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurological Disorder Diagnostics Market

• 25.1. Canada Neurological Disorder Diagnostics Market Overview
• 25.2. Canada Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurological Disorder Diagnostics Market

• 26.1. South America Neurological Disorder Diagnostics Market Overview
• 26.2. South America Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurological Disorder Diagnostics Market

• 27.1. Brazil Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurological Disorder Diagnostics Market

• 28.1. Middle East Neurological Disorder Diagnostics Market Overview
• 28.2. Middle East Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurological Disorder Diagnostics Market

• 29.1. Africa Neurological Disorder Diagnostics Market Overview
• 29.2. Africa Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurological Disorder Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Neurological Disorder Diagnostics Market Competitive Landscape
• 30.2. Neurological Disorder Diagnostics Market Company Profiles
  • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Neurological Disorder Diagnostics Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Amgen Inc.
• 31.3. Siemens Healthineers AG
• 31.4. Koninklijke Philips N.V.
• 31.5. GE HealthCare Technologies Inc.
• 31.6. Otsuka Pharmaceutical Co. Ltd.
• 31.7. Boston Scientific Corporation
• 31.8. Neurocrine Biosciences Inc.
• 31.9. Neusoft Medical Systems Co.Ltd.
• 31.10. Nihon Kohden Corporation
• 31.11. Natus Medical Incorporated
• 31.12. Esaote S.p.A
• 31.13. Canon Medical Systems Corporation
• 31.14. NeuroPace Inc.
• 31.15. Lifelines Neuro Company LLC

32. Global Neurological Disorder Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurological Disorder Diagnostics Market

34. Recent Developments In The Neurological Disorder Diagnostics Market

35. Neurological Disorder Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Neurological Disorder Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neurological Disorder Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neurological Disorder Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer